InSphero Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 73

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $26.9M

  • Investors
  • 9

InSphero General Information

Description

Developer of 3D-cell-based assay and scaffold-free 3D organ-on-a-chip technology designed to deliver biologically relevant insights for in vitro testing. The company's technology helps identify drugs and toxic liabilities with predictive power at early development stages, enabling biotechnological industries to make proper preclinical decisions, reduce development costs and shorten time to reduce animal use in testing.

Contact Information

Website
www.insphero.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Wagistrasse 27A
  • 8952 Schlieren
  • Switzerland
+41 044 000 00 00

InSphero Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InSphero Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 31-Mar-2023 $26.9M 000.00 00000 Completed Generating Revenue
10. Debt - General 01-Mar-2021 000.00 Completed Generating Revenue
9. Later Stage VC 13-Jun-2018 00.00 000.00 00000 Completed Generating Revenue
8. Grant 21-Oct-2015 00000 000.00 Completed Generating Revenue
7. Secondary Transaction - Private 12-Oct-2015 000.00 Completed Generating Revenue
6. Later Stage VC (Series C) 08-Jul-2015 000.00 000.00 000.00 Completed Generating Revenue
5. Early Stage VC (Series B) 13-Jun-2013 00.000 00.000 000.00 Completed Startup
4. Grant 27-Mar-2012 00.000 00.000 Completed Startup
3. Early Stage VC (Series A) 02-Aug-2010 $1.43M $2.71M 00.000 Completed Startup
2. Early Stage VC 01-Jan-2009 $1.14M $1.28M 00.000 Completed Startup
To view InSphero’s complete valuation and funding history, request access »

InSphero Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary Shares 000,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary Shares 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary Shares 00,000 00.000000 000.0 000.0 00 000.0 0.000
Ordinary Shares 0,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary Shares 00,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary Shares 45,460 $1.077644 $11.85 $11.85 1x $11.85 11.48%
Ordinary Shares 38,234 $1.077644 $36.64 $36.64 1x $36.64 9.66%
To view InSphero’s complete cap table history, request access »

InSphero Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of 3D-cell-based assay and scaffold-free 3D organ-on-a-chip technology designed to deliver biologically releva
Biotechnology
Schlieren, Switzerland
73 As of 2023
000.00
0000 0000-00-00
0000000000 0 000.00

000000

nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa q
0000000000000
San Diego, CA
00 As of 0000
000.00
000000&0

000000

te irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat
0000000000000
Berlin, Germany
00 As of 0000
0000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InSphero Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Organovo Formerly VC-backed San Diego, CA 00 000.00 000000&0
0000000 Corporation Berlin, Germany 00 0000000000
00000000 Venture Capital-Backed Orlando, FL 00 00000000
0000000 Venture Capital-Backed Leiden, Netherlands 00 000.00 0000000000 0 000.00
0000 0000000000 Venture Capital-Backed Saint-Sulpice, Switzerland 00 000.00 00000000000 000.00
You’re viewing 5 of 20 competitors. Get the full list »

InSphero Patents

  • 64

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 8

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

InSphero Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4225296-A1 Pharmaceutical combination for use in the treatment and/or prevention of diabetes Pending 06-Oct-2020 000000000
US-20230330188-A1 Pharmaceutical combination for use in the treatment and/or prevention of diabetes Pending 06-Oct-2020 000000000
EP-3981401-A1 Pharmaceutical combination for the treatment and/or prevention of diabetes comprising a calcium channel blocking agent and an incretin mimetic Inactive 06-Oct-2020 000000000 0
EP-3620233-A1 Transport device with an inner container Inactive 06-Sep-2018 00000000 0
EP-3846941-B1 Transport device with an inner container Active 06-Sep-2018 B01L9/52
To view InSphero’s complete patent history, request access »

InSphero Executive Team (18)

Name Title Board Seat Contact Info
Jan Lichtenberg Ph.D Co-Founder, Chief Executive Officer & Board Member
Jürg Gysi Ph.D President & Chairman
Filip Henzler Chief Financial Officer
Armin Wolf Ph.D Co-Chief Scientific Officer
Madhu Nag Ph.D Co-Chief Scientific Officer
You’re viewing 5 of 18 executive team members. Get the full list »

InSphero Board Members (10)

Name Representing Role Since
Beat Schillig Self Board Member 000 0000
Jan Lichtenberg Ph.D InSphero Co-Founder, Chief Executive Officer & Board Member 000 0000
Jürg Gysi Ph.D InSphero President & Chairman 000 0000
Thomas Pfisterer Self Board Member 000 0000
You’re viewing 4 of 10 board members. Get the full list »

InSphero Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InSphero Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Beat Schillig Angel (individual) Minority 000 0000 000000 0
ZEISS Ventures Corporate Venture Capital Minority 000 0000 000000 0
Jürg Gysi Angel (individual) Minority 000 0000 000000 0
Occident Group Venture Capital Minority 000 0000 000000 0
VentureLab Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial